Skip to main content
SpringerLink
Log in

A proposal for deciding when to prophylactically administer bone marrow (granulocyte) stimulatory factors to patients receiving cytotoxic chemotherapy

  • Editorial
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

The “Journal of Cancer Research and Clinical Oncology” publishes in loose succession “Editorials” and “Guest editorials” on current and/or controversial problems in experimental and clinical oncology. These contributions represent exclusively the personal opinion of the authors

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Steward WP (1993) Granulocyte and granulocyte-macrophage colonystimulating factors. Lancet 342:153–157

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cleveland Clinic Cancer Center, Department of Hematology/Medical Oncology, The Cleveland Clinic Foundation, 9500 Euclid avenue, 44195, Cleveland, Ohio, USA

    Maurie Markman

Authors
  1. Maurie Markman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Markman, M. A proposal for deciding when to prophylactically administer bone marrow (granulocyte) stimulatory factors to patients receiving cytotoxic chemotherapy. J Cancer Res Clin Oncol 120, 629–630 (1994). https://doi.org/10.1007/BF01245371

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01245371

Search

Navigation